Chimpanzee adenoviruses could be used to make vaccines, two new studies in the 4 January issue of the journal Science Translational Medicine report. The results hint that vaccines developed with chimp vectors can trigger immune protection against hepatitis C, a virus that affects the liver and is estimated to infect 170 million people globally. There are no vaccines to protect against the infection.